Home Featured Page 234

Featured

Latest

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

Book Club! Built To Burn: Tales of the Desert Carnies of Burning Man

COMPASS Pathways joins forces with King’s College London and South London...

Psychedelic Bulletin: Harvard Law School Launches Psychedelics Project; California Decrim. Bill...

PTSF66 – Philosophical Critiques, Legalization Updates, and Inclusive Research

Psilera Raises $2.5 Million with Oversubscribed Series Seed from Leading Institutional...

Navigating Psychedelics for Clinicians and Therapists Course: Informational Meeting with Joe...

PT251 – Kristina & Jonas of the Psychedelic Literacy Fund –...

Harvard Law School’s Petrie-Flom Center Launches Research Initiative on Psychedelics and...

Psyched Wellness Announces Matthew Singh Joins Team as CPG and Branding...

Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana

What Is Transpersonal Psychology and How Does It Relate to Psychedelics?

1...233234235...299 Page 234 of 299

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

Book Club – Trip Sitting

Book Club! Built To Burn: Tales of the Desert Carnies of Burning Man

COMPASS Pathways joins forces with King’s College London and South London...

Psychedelic Bulletin: Harvard Law School Launches Psychedelics Project; California Decrim. Bill...

PTSF66 – Philosophical Critiques, Legalization Updates, and Inclusive Research

Psilera Raises $2.5 Million with Oversubscribed Series Seed from Leading Institutional...

Navigating Psychedelics for Clinicians and Therapists Course: Informational Meeting with Joe...

PT251 – Kristina & Jonas of the Psychedelic Literacy Fund –...

Harvard Law School’s Petrie-Flom Center Launches Research Initiative on Psychedelics and...

Psyched Wellness Announces Matthew Singh Joins Team as CPG and Branding...

Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana

What Is Transpersonal Psychology and How Does It Relate to Psychedelics?

EDITOR PICKS

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY